(Q50634194)

17 March 2018

title

Direct-to-consumer testing: if consumers are not anxious, why are policymakers? (English)

1 reference

17 March 2018

1

Timothy Caulfield

1 reference

17 March 2018

publication date

11 April 2011

1 reference

17 March 2018

published in

Human Genetics

1 reference

17 March 2018

volume

130

1 reference

17 March 2018

issue

1

1 reference

17 March 2018

page(s)

23-25

1 reference

17 March 2018

ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Consumer perceptions of direct-to-consumer personalized genomic risk assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Effect of direct-to-consumer genomewide profiling to assess disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Disclosure of APOE genotype for risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Willingness to pay for genetic testing: a study of attitudes in a Canadian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Understanding FDA Regulation of DTC Genetic Tests within the Context of Administrative Law

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Deflating the Genomic Bubble

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Which way for genetic-test regulation? Assign regulation appropriate to the level of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-011-0987-8

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours

21 January 2018

1 reference

12 December 2020

Is modern genetics a blind alley? Yes

1 reference

12 December 2020

Science and regulation. Regulating direct-to-consumer personal genome testing

1 reference

12 December 2020

Being more realistic about the public health impact of genomic medicine

1 reference

12 December 2020

Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents

1 reference

12 December 2020

10.1007/S00439-011-0987-8

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018